Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Breath methionine and oxidant stress in critically ill patients receiving Dipeptiven
2006-003571-12Phase 2Completed
- Sponsor
- Barts Health NHS Trust
- Start
- Sep 2006
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of alanyl glutamine in critical illness and sepsis (3 arms), sponsored by Barts Health NHS Trust. Primary endpoints: 13C recovery rate, Peak 13C recovery and 1 more. Started Sep 2006; status: completed.
02
Drugs
alanyl glutamine
03
Conditions
critical illnesssepsis
Beyond the preview
Go deeper on 2006-003571-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003571-12.